AI-Based Next-Generation-Phenotyping for Rare Disease Diagnosis
Rare diseases, which affect more than 300 million people worldwide, are often difficult to diagnose. Many patients wait five years …
Biopharma Insights
How AI, Graphs, and GraphRAG Are Set to Revolutionize Alzheimer's Gene Research and Treatment
An estimated 6.9 million Americans aged 65 and older are living with Alzheimer’s. Without major medical breakthroughs, that number is …
Novotech Report: Over 800 Global IPF Trials Since 2020, Led by Asia-Pacific
Novotech CRO has released a global market analysis focused on the clinical trial landscape for Idiopathic Pulmonary Fibrosis (IPF), identifying …
Report: Nearly 80% of Life Sciences Leaders Considering Virtual Models for Observational Research
A new industry report from PicnicHealth reveals that nearly 80% of life sciences leaders are open to using virtual models …
AI in Drug Safety: From Concept to Reality, The Industry's Path Forward
Pharmaceutical companies are dealing with an unprecedented volume of safety data with artificial intelligence moving from theoretical applications to practical …
Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?
The field of oncology is experiencing a proliferation of cancer therapies. In 2024 alone, the U.S. Food and Drug Administration …
What CROs Cite as Their Top Clinical Trial Challenges and How They Plan to Overcome Them in 2025
In a rapidly evolving clinical research landscape, there is a greater need now more than ever for pharma and biotech …
21 Life Science Marketplaces to Try in 2024
(Last Update: December 2024, by adding Lab Spend, Labviva and more) A life sciences marketplace is an online platform that operates with a …
Chemistry CROs at a Crossroads: How SpiroChem Is Adapting to Market Shifts in 2025 and Beyond
As we approach 2025, the role of chemistry Contract Research Organizations (CROs) is undergoing profound transformation. Chemistry is no longer …
Legal and Governance Considerations in AI for Drug Discovery: New Paradigms and 2025 Outlook
Just in time for 2025 prediction season, a survey of the emerging AI drug discovery landscape, prepared by Chris Bradbury, …
The AI-driven Development Journey of ISM5411, a Potential Breakthrough Treatment for Inflammatory Bowel Disease
Inflammatory Bowel Disease (IBD), a chronic and debilitating autoimmune disorder that includes ulcerative colitis and Crohn’s disease, impacts millions of …
The Importance of Accurate Patient Matching for AI Projects
Artificial intelligence (AI) is revolutionizing healthcare by enhancing workflows, enabling earlier diagnoses, and paving the way for personalized care. However, …